Luca Laurenti

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 62

Top Venues

Hematological oncology

American journal of hematology

Cancers

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Giovanni D'Arena, Candida Vitale, Giuseppe Pietrantuono, Oreste Villani, Giovanna Mansueto, Fiorella D'Auria, Teodora Statuto, Simona D'Agostino, Rosalaura Sabetta, Angela Tarasco, Idanna Innocenti, Francesco Autore, Alberto Fresa, Luciana Valvano, Annamaria Tomasso, Lorenzo Cafaro, Daniela Lamorte, Luca Laurenti
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers 16 (2) (2024)
Eugenio Galli, Maria Assunta Limongiello, Elisabetta Metafuni, Sabrina Giammarco, Alberto Fresa, Nicola Piccirillo, Maria Bianchi, Luca Laurenti, Federica Sorà, Patrizia Chiusolo, Simona Sica
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity. American journal of hematology 99 (4) (2024)
Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Luca Stirparo, Antonio Mosca, Francesco Iadevaia, Francesco Autore, Paolo Ghia, Luca Laurenti
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed. Cancers 16 (11) (2024)
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. Cancers 16 (6) (2024)
Francesca Romana Mauro, Potito Rosario Scalzulli, Lydia Scarfò, Carla Minoia, Roberta Murru, Paolo Sportoletti, Ferdinando Frigeri, Francesco Albano, Nicola Di Renzo, Alessandro Sanna, Luca Laurenti, Massimo Massaia, Ramona Cassin, Marta Coscia, Caterina Patti, Elsa Pennese, Agostino Tafuri, Annalisa Chiarenza, Piero Galieni, Omar Perbellini, Carmine Selleri, Catello Califano, Felicetto Ferrara, Antonio Cuneo, Marco Murineddu, Gaetano Palumbo, Ilaria Scortechini, Alessandra Tedeschi, Livio Trentin, Marzia Varettoni, Fabrizio Pane, Anna Marina Liberati, Francesco Merli, Lucia Morello, Gerardo Musuraca, Monica Tani, Adalberto Ibatici, Giulia Regazzoni, Michele Di Candia, Maria Palma, Danilo Arienti, Stefano Molica
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study. Cancers 16 (6) (2024)
Enrica Antonia Martino, Francesca Romana Mauro, Gianluigi Reda, Luca Laurenti, Andrea Visentin, Anna Maria Frustaci, Ernesto Vigna, Sara Pepe, Gioacchino Catania, Giacomo Loseto, Roberta Murru, Annalisa Chiarenza, Paolo Sportoletti, Maria Ilaria Del Principe, Roberta Laureana, Marta Coscia, Sara Galimberti, Eleonora Ferretti, Antonella Zucchetto, Riccardo Bomben, Jerry Polesel, Alessandra Tedeschi, Davide Rossi, Francesco Angotzi, Antonino Neri, Fortunato Morabito, Valter Gattei, Massimo Gentile
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort. Hematological oncology 42 (1) (2024)
Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Luca Stirparo, Antonio Mosca, Francesco Iadevaia, Francesco Autore, Paolo Ghia, Luca Laurenti
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed. Cancers 16 (11) (2024)
Giovanni D'Arena, Candida Vitale, Giuseppe Pietrantuono, Oreste Villani, Giovanna Mansueto, Fiorella D'Auria, Teodora Statuto, Simona D'Agostino, Rosalaura Sabetta, Angela Tarasco, Idanna Innocenti, Francesco Autore, Alberto Fresa, Luciana Valvano, Annamaria Tomasso, Lorenzo Cafaro, Daniela Lamorte, Luca Laurenti
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers 16 (2) (2024)
Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Luana Schiattone, Nilla Maschio, Davide Facchinelli, Francesco Marchesi, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Idanna Innocenti, Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study. American journal of hematology 99 (5) (2024)
Eugenio Galli, Maria Assunta Limongiello, Elisabetta Metafuni, Sabrina Giammarco, Alberto Fresa, Nicola Piccirillo, Maria Bianchi, Luca Laurenti, Federica Sorà, Patrizia Chiusolo, Simona Sica
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity. American journal of hematology 99 (4) (2024)
Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Luana Schiattone, Nilla Maschio, Davide Facchinelli, Francesco Marchesi, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Idanna Innocenti, Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study. American journal of hematology (2024)
Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Luana Schiattone, Nilla Maschio, Davide Facchinelli, Francesco Marchesi, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Idanna Innocenti, Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study. American journal of hematology 99 (5) (2024)
Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, Rita Fazzi, Alessandro Sanna, Jacopo Olivieri, Ilaria Scortechini, Maria Ilaria Del Principe, Paolo Sportoletti, Luana Schiattone, Nilla Maschio, Davide Facchinelli, Francesco Marchesi, Marta Coscia, Alessandra Tedeschi, Livio Trentin, Idanna Innocenti, Anna Candoni, Alessandro Busca, Livio Pagano, Luca Laurenti
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study. American journal of hematology 99 (5) (2024)
Eugenio Galli, Maria Assunta Limongiello, Elisabetta Metafuni, Sabrina Giammarco, Alberto Fresa, Nicola Piccirillo, Maria Bianchi, Luca Laurenti, Federica Sorà, Patrizia Chiusolo, Simona Sica
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity. American journal of hematology 99 (4) (2024)
Eugenio Galli, Maria Assunta Limongiello, Elisabetta Metafuni, Sabrina Giammarco, Alberto Fresa, Nicola Piccirillo, Maria Bianchi, Luca Laurenti, Federica Sorà, Patrizia Chiusolo, Simona Sica
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity. American journal of hematology (2024)
Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, Emilia Iannella, Morena Caira, Paola Finsinger, Silvia Schifano, Benedetta Neri, Stefano Molica, Francesca Romana Mauro
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological oncology (2023)
Andrea Visentin, Francesca Romana Mauro, Lydia Scarfò, Massimo Gentile, Lucia Farina, Gianluigi Reda, Isacco Ferrarini, Giulia Proietti, Enrico Derenzini, Francesca Cibien, Candida Vitale, Alessandro Sanna, Daniela Pietrasanta, Monia Marchetti, Roberta Murru, Gian Matteo Rigolin, Paolo Sportoletti, Valentina Trimarco, Chiara Adele Cavarretta, Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Ivan Zatta, Luca Laurenti, Stefano Molica, Marta Coscia, Paolo Ghia, Robin Foà, Antonio Cuneo, Livio Trentin
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study. American journal of hematology (2023)
Luca Laurenti, Lydia Scarfò, Anna Maria Frustaci, Alessandro Sanna, Emilia Iannella, Morena Caira, Paola Finsinger, Silvia Schifano, Benedetta Neri, Stefano Molica, Francesca Romana Mauro
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience. Hematological oncology (2023)
Paolo Sportoletti, Luca Laurenti, Annalisa Chiarenza, Gianluca Gaidano, Elisa Albi, Francesca Romana Mauro, Francesco Angotzi, Daniele Vallisa, Fabrizio Pane, Antonio Cuneo, Francesco Albano, Giulia Zamprogna, Marta Coscia, Alessandro Gozzetti, Gianluigi Reda, Morena Caira, Paola Finsinger, Giuliana Gualberti, Emilia Iannella, Simona Malgieri, Stefano Molica
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. Hematological oncology (2023)
Fortunato Morabito, Giovanni Tripepi, Francesca Romana Mauro, Luca Laurenti, Gianluigi Reda, Riccardo Moia, Adalgisa Condoluci, Iolanda Vincelli, Annalisa Chiarenza, Ernesto Vigna, Enrica Antonia Martino, Antonella Bruzzese, Sabrina Mezzatesta, Roberta Laureana, Giovanna Cutrona, Francesco Di Raimondo, Gilberto Fronza, Antonella Zucchetto, Riccardo Bomben, Francesca Maria Rossi, Jacopo Olivieri, Francesco Zaja, Davide Rossi, Gianluca Gaidano, Maria Ilaria Del Principe, Fiorella Ilariucci, Giovanni Del Poeta, Manlio Ferrarini, Antonino Neri, Valter Gattei, Massimo Gentile
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia. American journal of hematology (2023)
Idanna Innocenti, Alberto Fresa, Annamaria Tomasso, Michela Tarnani, Laura De Padua, Giulia Benintende, Raffaella Pasquale, Eugenio Galli, Francesca Morelli, Diana Giannarelli, Francesco Autore, Luca Laurenti
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience. Cancers 15 (23) (2023)
Francesco Autore, Idanna Innocenti, Gianluigi Reda, Andrea Visentin, Candida Vitale, Alfonso Piciocchi, Alberto Fresa, Monica M A Leone, Lucia Farina, Giulia Quaresmini, Claudia Baratè, Annamaria Giordano, Angela Ferrari, Ilaria Angeletti, Maria Rosaria De Paolis, Lara Malerba, Federico Chiurazzi, Giacomo Loseto, Gioacchino Catania, Paolo Sportoletti, Ilaria Scortechini, Riccardo Moia, Massimo Gentile, Gian Matteo Rigolin, Veronica Mattiello, Valter Gattei, Marta Coscia, Francesco Angotzi, Robin Foà, Antonio Cuneo, Luca Laurenti
Lymphadenopathy as a predictor of progression during venetoclax treatment in chronic lymphocytic leukemia. A campus chronic lymphocytic leukemia study. Hematological oncology (2023)
Francesco Autore, Alice Ramassone, Luca Stirparo, Sara Pagotto, Alberto Fresa, Idanna Innocenti, Rosa Visone, Luca Laurenti
Role of microRNAs in Chronic Lymphocytic Leukemia. International journal of molecular sciences 24 (15) (2023)
Elisabetta Metafuni, Irene Maria Cavattoni, Teresa Lamparelli, Anna Maria Raiola, Anna Ghiso, Federica Galaverna, Francesca Gualandi, Carmen Di Grazia, Alida Dominietto, Riccardo Varaldo, Alessio Signori, Patrizia Chiusolo, Federica Sora', Sabrina Giammarco, Luca Laurenti, Simona Sica, Emanuele Angelucci, Andrea Bacigalupo
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation. Blood advances 6 (7) (2022)
Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci, Riccardo Moia, Clara Deambrogi, Silvia Rasi, Francesco Autore, Michele Merli, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo', Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta, Valeria Spina, Alessio Bruscaggin, Katia Pini, Deborah Piffaretti, Maria Cristina Pirosa, Matin Salehi, Joyce Marques de Almeida, Jakob Passweg, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Georg Stussi, Valter Gattei, Paolo Ghia, Michael Gregor, Francesco Passamonti, Luca Laurenti, Gianluca Gaidano, Alessandra Tedeschi, Davide Rossi, Adalgisa Condoluci
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia. Hematological oncology (2022)
Pier Luigi Luigi Zinzani, Maurizio Martelli, Simone Ferrero, Massimo Gentile, Luca Laurenti, Francesca Romana Mauro, Paolo Sportoletti, Alessandra Tedeschi, Marzia Varettoni, Chiara Rusconi
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement. Hematological oncology 40 (4) (2022)
Shai Levi, Yotam Bronstein, Neta Goldschmidt, Fortunato Morabito, Tomer Ziv-Baran, Giovanni Del Poeta, Osnat Bairey, Maria Ilaria Del Principe, Riva Fineman, Francesca Romana Mauro, Odit Gutwein, Gianluigi Reda, Rosa Ruchlemer, Paolo Sportoletti, Luca Laurenti, Lev Shvidel, Marta Coscia, Tamar Tadmor, Marzia Varettoni, Ariel Aviv, Roberta Murru, Andrei Braester, Annalisa Chiarenza, Andrea Visentin, Daniela Pietrasanta, Giacomo Loseto, Antonella Zucchetto, Riccardo Bomben, Jacopo Olivieri, Antonio Neri, Davide Rossi, Gianluca Gaidano, Livio Trentin, Robin Foà, Antonio Cuneo, Chava Perry, Valter Gattei, Massimo Gentile, Yair Herishanu
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real-World" study. American journal of hematology (2022)
Alberto Fresa, Francesco Autore, Alfonso Piciocchi, Gioacchino Catania, Andrea Visentin, Annamaria Tomasso, Marina Moretti, Candida Vitale, Annalisa Chiarenza, Francesca Morelli, Paolo Sportoletti, Roberto Marasca, Giuseppe Sapienza, Annarosa Cuccaro, Roberta Murru, Alessandro Sanna, Caterina Patti, Ilaria Angeletti, Marta Coscia, Livio Trentin, Daniela Pietrasanta, Idanna Innocenti, Luca Laurenti
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood advances 6 (13) (2022)
Idanna Innocenti, Giulia Benintende, Annamaria Tomasso, Alberto Fresa, Francesco Autore, Luigi Maria Larocca, Luca Laurenti
Richter transformation in Chronic Lymphocytic Leukemia. Hematological oncology (2022)
Lydia Scarfò, Silvia Heltai, Elisa Albi, Eloise Scarano, Luana Schiattone, Lucia Farina, Riccardo Moia, Marina Deodato, Andrea Ferrario, Marina Motta, Gianluigi Reda, Rosaria Sancetta, Marta Coscia, Paolo Rivela, Luca Laurenti, Marzia Varettoni, Eleonora Perotta, Antonella Capasso, Pamela Ranghetti, Maria Colia, Paolo Ghia
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL. Blood 140 (22) (2022)
Gianluigi Reda, Veronica Mattiello, Anna Maria Frustaci, Andrea Visentin, Francesca Romana Mauro, Idanna Innocenti, Massimo Gentile, Diana Giannarelli, Alessandro Noto, Ramona Cassin, Antonino Neri, Luca Laurenti, Alessandra Tedeschi
Ibrutinib in patients over 80 with chronic lymphocytic leukemia: a multicenter Italian cohort. Blood advances (2022)
Idanna Innocenti, Annamaria Tomasso, Giulia Benintende, Francesco Autore, Alberto Fresa, Florenzia Vuono, Luca Stirparo, Eugenio Galli, Giovanni D'Arena, Federica Sorà, Dimitar Efremov, Luca Laurenti
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics. Hematological oncology 40 (3) (2022)
Stefano Molica, Diana Giannarelli, Andrea Visentin, Gianluigi Reda, Paolo Sportoletti, Anna Maria Frustaci, Annalisa Chiarenza, Stefania Ciolli, Candida Vitale, Luca Laurenti, Lorenzo De Paoli, Roberta Murru, Massimo Gentile, Riccardo Moia, Gian Matteo Rigolin, Luciano Levato, Annamaria Giordano, Giovanni Del Poeta, Caterina Stelitano, Marina Deodato, Claudia Ielo, Alessandro Noto, Valerio Guarente, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foa', Livio Trentin, Francesca Romana Mauro
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model. American journal of hematology 97 (5) (2022)
Claudio Martines, Supriya Chakraborty, Marija Vujovikj, Stefania Gobessi, Tiziana Vaisitti, Silvia Deaglio, Luca Laurenti, Aleksandar J Dimovski, Dimitar G Efremov
Macrophage- and BCR-derived but not TLR-derived signals support the growth of CLL and Richter syndrome murine models in vivo. Blood 140 (22) (2022)
Riccardo Moia, Riccardo Dondolin, Maria Stefania De Propris, Donatella Talotta, Samir Mouhssine, Francesca Perutelli, Gianluigi Reda, Veronica Mattiello, Gian Matteo Rigolin, Marina Motta, Jacopo Olivieri, Renato Fanin, Omar Perbellini, Isacco Ferrarini, Francesca Romana Mauro, Ilaria Del Giudice, Luca Laurenti, Annamaria Tomasso, Massimo Gentile, Anna Maria Frustaci, Alessandra Tedeschi, Alessandro Gozzetti, Caterina Stelitano, Chiara Rusconi, Carol Moreno, Francesco Forconi, Roberto Marasca, Marta Coscia, Davide Rossi, Robin Foà, Gianluca Gaidano
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia. Hematological oncology (2022)
Francesco Autore, Alberto Fresa, Idanna Innocenti, Maria Ilaria Del Principe, Raffaele Maglione, Caterina Stefanizzi, Sabrina Pelliccia, Azzurra Romeo, Giuseppe Cimino, Elena Papa, Laura De Padua, Alessandro Andriani, Andrea Mengarelli, Agostino Tafuri, Concetta Ditto, Francesca Romana Mauro, Giovanni Del Poeta, Luca Laurenti
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas. Hematological oncology (2022)
Giovanni D'Arena, Alessandro Sgambato, Silvestro Volpe, Giuseppe Coppola, Rachele Amodeo, Virginia Tirino, Fiorella D'Auria, Teodora Statuto, Luciana Valvano, Giuseppe Pietrantuono, Silvia Deaglio, Dimitar Efremov, Luca Laurenti, Antonella Aiello
Flow cytometric evaluation of measurable residual disease in chronic lymphocytic leukemia: Where do we stand? Hematological oncology (2022)
Candida Vitale, Chiara Salvetti, Valentina Griggio, Marika Porrazzo, Luana Schiattone, Giulia Zamprogna, Andrea Visentin, Francesco Vassallo, Ramona Cassin, Gian Matteo Rigolin, Roberta Murru, Luca Laurenti, Paolo Rivela, Monia Marchetti, Elsa Pennese, Massimo Gentile, Elia Boccellato, Francesca Perutelli, Maria Chiara Montalbano, Lorenzo De Paoli, Gianluigi Reda, Lorella Orsucci, Livio Trentin, Antonio Cuneo, Alessandra Tedeschi, Lydia Scarfò, Gianluca Gaidano, Francesca Romana Mauro, Robin Foà, Mario Boccadoro, Marta Coscia
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. Blood 137 (25) (2021)
Alberto Fresa, Francesco Autore, Eugenio Galli, Annamaria Tomasso, Luca Stirparo, Idanna Innocenti, Luca Laurenti
Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review. Journal of clinical medicine 10 (21) (2021)
Francesco Autore, Raffaella Pasquale, Idanna Innocenti, Alberto Fresa, Federica Sora', Luca Laurenti
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers 13 (22) (2021)
Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Romana Mauro, Antonella Zucchetto, Ernesto Vigna, Enrica Antonia Martino, Francesco Mendicino, Cirino Botta, Daniele Caracciolo, Ramona Cassin, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. American journal of hematology 96 (5) (2021)
Fortunato Morabito, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Anna Grazia Recchia, Francesca Romana Mauro, Antonella Zucchetto, Hamdi Al-Janazreh, Enrica Antonia Martino, Ernesto Vigna, Giovanni Tripepi, Graziella D'Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Giovanna Cutrona, Ozren Jaksic, Jacopo Olivieri, Davide Rossi, Francesco Di Raimondo, Antonio Cuneo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases. American journal of hematology 96 (8) (2021)
Francesca Romana Mauro, Diana Giannarelli, Andrea Visentin, Gianluigi Reda, Paolo Sportoletti, Anna Maria Frustaci, Annalisa Chiarenza, Stefania Ciolli, Candida Vitale, Luca Laurenti, Lorenzo De Paoli, Roberta Murru, Massimo Gentile, Gian Matteo Rigolin, Luciano Levato, Annamaria Giordano, Giovanni Del Poeta, Caterina Stelitano, Claudia Ielo, Alessandro Noto, Valerio Guarente, Stefano Molica, Marta Coscia, Alessandra Tedeschi, Gianluca Gaidano, Antonio Cuneo, Robin Foà, Maurizio Martelli, Corrado Girmenia, Giuseppe Gentile, Livio Trentin
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Cancers 13 (13) (2021)
Mirco Di Marco, Serena Veschi, Paola Lanuti, Alice Ramassone, Stefania Pacillo, Sara Pagotto, Felice Pepe, Jonahunnatha Nesson George-William, Claudia Curcio, Marco Marchisio, Sebastiano Miscia, Idanna Innocenti, Francesco Autore, Barbara Vannata, Patrizia Di Gregorio, Mario Di Gioacchino, Silvia Valentinuzzi, Manuela Iezzi, Renato Mariani-Costantini, Luigi Maria Larocca, Luca Laurenti, Angelo Veronese, Rosa Visone
Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response. Cancers 13 (2) (2021)
Supriya Chakraborty, Claudio Martines, Fabiola Porro, Ilaria Fortunati, Alice Bonato, Marija Dimishkovska, Silvano Piazza, Brijesh Singh Yadav, Idanna Innocenti, Rosa Fazio, Tiziana Vaisitti, Silvia Deaglio, Alberto Zamo, Aleksandar J Dimovski, Luca Laurenti, Dimitar G Efremov
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation. Blood 138 (12) (2021)
Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro, Annalisa Chiarenza, Marta Coscia, Stefania Ciolli, Gianluigi Reda, Luca Laurenti, Marzia Varettoni, Roberta Murru, Claudia Baratè, Paolo Sportoletti, Antonino Greco, Chiara Borella, Valentina Rossi, Marina Deodato, Annalisa Biagi, Giulia Zamprogna, Angelo Curto Pelle, Gianfranco Lapietra, Candida Vitale, Francesca Morelli, Ramona Cassin, Alberto Fresa, Chiara Cavalloni, Massimiliano Postorino, Claudia Ielo, Roberto Cairoli, Francesco Di Raimondo, Marco Montillo, Giovanni Del Poeta
Do age, fitness and concomitant medications influence management and outcomes of CLL patients treated with ibrutinib? Blood advances (2021)
Fortunato Morabito, Giovanni Tripepi, Giovanni Del Poeta, Francesca Romana Mauro, Gianluigi Reda, Paolo Sportoletti, Luca Laurenti, Marta Coscia, Yair Herishanu, Sabrina Bossio, Marzia Varettoni, Roberta Murru, Annalisa Chiarenza, Andrea Visentin, Adalgisa Condoluci, Riccardo Moia, Daniela Pietrasanta, Giacomo Loseto, Ugo Consoli, Ilaria Scortechini, Francesca Romana Mauro, Antonella Zucchetto, Hamdi Al-Janazreh, Ernesto Vigna, Enrica Antonia Martino, Ramona Cassin, Graziella D Arrigo, Sara Galimberti, Angela Rago, Ilaria Angeletti, Annalisa Biagi, Ilaria Del Giudice, Riccardo Bomben, Antonino Neri, Gilberto Fronza, Paola Menichini, Paola Menichini, Jacopo Olivieri, Giovanna Cutrona, Davide Rossi, Antonio Cuneo, Francesco Di Raimondo, Gianluca Gaidano, Aaron Polliack, Livio Trentin, Robin Foà, Manlio Ferrarini, Valter Gattei, Massimo Gentile
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials. American journal of hematology 96 (8) (2021)
Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, Giulia Quaresmini, Lydia Scarfò, Francesca Romana Mauro, Marina Motta, Francesca Maria Quaglia, Livio Trentin, Andrea Ferrario, Luca Laurenti, Gianluigi Reda, Angela Ferrari, Daniela Pietrasanta, Paolo Sportoletti, Francesca Re, Lorenzo De Paoli, Myriam Foglietta, Annamaria Giordano, Monia Marchetti, Lucia Farina, Giovanni Del Poeta, Marzia Varettoni, Federico Chiurazzi, Roberto Marasca, Lara Malerba, Adalberto Ibatici, Maria Chiara Tisi, Vittorio Stefoni, Monica Leone, Claudia Baratè, Jacopo Olivieri, Roberta Murru, Massimo Gentile, Alessandro Sanna, Alessandro Gozzetti, Valter Gattei, Daniela Gottardi, Enrico Derenzini, Luciano Levato, Lorella Orsucci, Giuseppa Penna, Annalisa Chiarenza, Robin Foà
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report. Hematological oncology 39 (4) (2021)
Alberto Fresa, Francesco Autore, Idanna Innocenti, Alfonso Piciocchi, Annamaria Tomasso, Francesca Morelli, Federica Sorà, Simona Sica, Valerio De Stefano, Luca Laurenti
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia. Hematological oncology 39 (3) (2021)
Francesca Romana Mauro, Francesca Paoloni, Stefano Molica, Gianluigi Reda, Livio Trentin, Paolo Sportoletti, Monia Marchetti, Daniela Pietrasanta, Roberto Marasca, Gianluca Gaidano, Marta Coscia, Caterina Stelitano, Donato Mannina, Nicola Di Renzo, Fiorella Ilariucci, Anna Marina Liberati, Lorella Orsucci, Francesca Re, Monica Tani, Gerardo Musuraca, Daniela Gottardi, Pier Luigi Luigi Zinzani, Alessandro Gozzetti, Annalia Molinari, Massimo Gentile, Annalisa Chiarenza, Luca Laurenti, Marzia Varettoni, Adalberto Ibatici, Roberta Murru, Valeria Ruocco, Ilaria Del Giudice, Maria Stefania De Propris, Irene Della Starza, Sara Raponi, Mauro Nanni, Paola Fazi, Antonino Neri, Anna Guarini, Gian Matteo Rigolin, Alfonso Piciocchi, Antonio Cuneo, Robin Foà
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study. Cancers 14 (1) (2021)
Andrea Visentin, Francesca Romana Mauro, Francesca Cibien, Candida Vitale, Gianluigi Reda, Alberto Fresa, Stefania Ciolli, Daniela Pietrasanta, Monia Marchetti, Roberta Murru, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Lydia Scarfò, Paolo Sportoletti, Stefano Pravato, Francesco Piazza, Marta Coscia, Luca Laurenti, Stefano Molica, Robin Foà, Antonio Cuneo, Livio Trentin
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study. American journal of hematology 97 (3) (2021)
Gian Matteo Rigolin, Francesco Cavazzini, Alfonso Piciocchi, Valentina Arena, Andrea Visentin, Gianluigi Reda, Giulia Zamprogna, Francesca Cibien, Orsola Vitagliano, Marta Coscia, Lucia Farina, Gianluca Gaidano, Roberta Murru, Marzia Varettoni, Rossella Paolini, Paolo Sportoletti, Daniela Pietrasanta, Anna Lia Molinari, Francesca M Quaglia, Luca Laurenti, Roberto Marasca, Monia Marchetti, Francesca R Mauro, Enrico Crea, Marco Vignetti, Massimo Gentile, Marco Montillo, Robin Foà, Antonio Cuneo, null null
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. Hematological oncology 39 (3) (2021)
Giovanni D'Arena, Candida Vitale, Marta Coscia, Daniela Lamorte, Giuseppe Pietrantuono, Francesca Perutelli, Fiorella D'Auria, Teodora Statuto, Luciana Valvano, Annamaria Tomasso, Valentina Griggio, Rebecca Jones, Giovanna Mansueto, Oreste Villani, Simona D'Agostino, Vito Viglioglia, Vincenzo De Feo, Fabrizio Calapai, Carmen Mannucci, Alessandro Sgambato, Dimitar G Efremov, Luca Laurenti
CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia. Cancers 13 (16) (2021)
Idanna Innocenti, Federica Sora, Francesco Autore, Patrizia Chiusolo, Sabrina Giammarco, Elisabetta Metafuni, Andrea Bacigalupo, Simona Sica, Luca Laurenti
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation. Hematological oncology 39 (2) (2020)
Dimitar G Efremov, Sven Turkalj, Luca Laurenti
Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies. Cancers 12 (6) (2020)
Luca Laurenti, Dimitar G Efremov
Therapeutic Targets in Chronic Lymphocytic Leukemia. Cancers 12 (11) (2020)
Andrea Corbingi, Idanna Innocenti, Annamaria Tomasso, Raffaella Pasquale, Andrea Visentin, Marzia Varettoni, Elena Flospergher, Francesco Autore, Francesca Morelli, Livio Trentin, Gianluigi Reda, Dimitar G Efremov, Luca Laurenti
Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia. British journal of haematology 190 (6) (2020)
Patrizia Chiusolo, Stefania Bregante, Sabrina Giammarco, Teresa Lamparelli, Lucia Casarino, Alida Dominietto, Anna Maria Raiola, Elisabetta Metafuni, Carmen Di Grazia, Francesca Gualandi, Federica Sorà, Luca Laurenti, Simona Sica, Gianni Barosi, Fabio Guolo, Monica Rossi, Elena Rossi, Alessandro Vannucchi, Alessio Signori, Valerio De Stefano, Andrea Bacigalupo, Emanuele Angelucci
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen. American journal of hematology 96 (2) (2020)
Idanna Innocenti, Francesca Morelli, Francesco Autore, Annamaria Tomasso, Andrea Corbingi, Silvia Bellesi, Tommaso Za, Valerio De Stefano, Luca Laurenti
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax. Leukemia & lymphoma 60 (12) (2019)
Francesco Autore, Alberto Fresa, Idanna Innocenti, Annamaria Tomasso, Francesca Morelli, Andrea Corbingi, Federica Sorà, Luca Laurenti
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience. Hematological oncology 37 (5) (2019)
Francesco Autore, Idanna Innocenti, Marco Luigetti, Nicola Piccirillo, Federica Sora, Patrizia Chiusolo, Simona Sica, Andrea Bacigalupo, Luca Laurenti
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome. Hematological oncology 36 (2) (2017)

Luca Laurenti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Luca Laurenti